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Abstract NADH-Coenzyme Q reductase was assayed in plate- 
let mitocbondrial membranes obtained from 19 pools of two ve- 
nous blood samples from female young (19-30 years) individuals 
and 18 pools from aged ones (66-107 years). The enzyme activi- 
ties were not significantly changed in the two groups, but a de- 
crease of sensitivity to the specific inhibitor, rotenone, occurred 
in a substantial number of aged individuals. The results are in 
agreement with the predictions of the mitochondrial theory of 
ageing and may be used to develop a sensitive biomarker of the 
ageing process. 
Key wor& Ageing; Platelet mitochondrion; Complex I; 
Rotenone sensitivity 
1. Introduction 
According to the mitochondrial theory of ageing [ 11, accumu- 
lation of somatic mutations in mitochondrial DNA (mtDNA), 
due to continuous attack by oxygen-derived radicals and other 
toxic species, is a key factor in determining the decline in cell 
performance that characterizes senescence. 
Mitochondrial DNA encodes for 13 hydrophobic polypep- 
tide chains of the four enzymic complexes of the mitochondrial 
inner membrane involved in oxidative phosphorylation [2]. 
Since 7 out of the 13 chains are subunits of Complex I (NADH- 
Coenzyme Q reductase) of the respiratory chain, it is predicted 
that the highest frequency of mutations would affect this en- 
zyme. A decreased activity of Complex I was indeed found in 
experimental animal tissues and muscle biopsies from aged 
individuals [3-51. 
Recently, the medical interest in Complex I has increased in 
view of its involvement in a number of genetic and acquired 
degenerative diseases [6]; particularly interesting is Leber’s he- 
reditary optic neuropathy (LHON), a maternally inherited dis- 
ease associated to mtDNA point mutations: the most frequent 
form of LHON is associated to increased resistance to ro- 
tenone. a classical inhibitor of the Complex I that binds to the 
hydrophobic sector [7]. 
Since the common 5 kb deletion. and others as well, de- 
scribed to increase in ageing, encompass a region including 
subunits of Complex I [8], we have investigated the specific 
activity and turnover of NADH-Coenzyme Q reductase and its 
rotenone sensitivity, in an attempt to find a marker of the 
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bioenergetic lesions occurring in senescence. For this pilot 
study we have employed mitochondrial membranes from 
human platelets, as these cells are of easy sampling and do not 
involve invasive procedures. 
2. Materials and methods 
Platelets were obtained from venous blood samples (60 ml each), 
pooled with two by two, from 38 female young (19-30 years) individuals 
(19 pools) and 36 aged ones (66-107 years; 18 pools) selected by the lack 
of systemic and haematic diseases. Since it has been easier to recruit old 
female individuals from the hospitalized group of aged subjects, we 
decided to consider only females to keep the group homogeneous. 
Blood samples of each pool were from age-matched individuals. 
Platelets were purified following the method of Blass [9] with the 
following modifications; erythrocytes were sedimented in 70000 dex- 
trane, 0.9% NaCl at room temperature for 30 min. The upper phase was 
centrifuged (3,000 x g. 3 min) and an aliquot of the platelet rich plasma 
supernatant was tested by a Cell Counter to determine the mean platelet 
volume; the remainder was centrifuged at 4,000 x g for 25 min then 
washed in 20 mM sodium phosphate, 0.12 M NaCI, pH 7.4 (5,000 x g 
IO min). In order to prepare membrane fragments including mitochon- 
drial particles, the pellet of platelets was treated as described by Degli 
Esposti et al. [7] with the following modifications: the pellet was sub- 
jected to osmotic shock to remove residual erythrocytes, washed 
(15,000 xg. 10 min) in 150 mM KC], 50 mM Tris-HCl, 1 mM EDTA, 
pH 7.4. and mildly sonicated five times at 10-s periods (150 Hz) with 
50-s intervals. 
The platelet membrane fragments, that include the mitochondrial 
ones, were diluted 1:l in sucrose 0.25 M, Tris 30 mM, EDTA 1 mM, 
pH 7.7, then separated from the heavier cell debris by centrifugation 
(33,000 x g. 10 min); the supernatant was then ultracentrifuged 
(100,000 x g.40 min) and the pellet was suspended in the same buffer. 
The membrane preparation contained ruptured mitochondrial frag- 
ments lacking permeability barriers, as ascertained by the presence of 
both NADH oxidation and cytochrome oxidase activities. Protein con- 
tent was assayed according to Lowry et al. [IO]. 
Complex I activity (NADH-CoQ reductase, EC 1.6.99.3) was as- 
sayed &lizing an analog of the natural acceptor Coenzyme Q, decyl- 
ubiauinone (DB. from Sigma. St. Louis. MO) 1111. The assay was 
perf’ormed [12] at 32°C in50 mM K-phosphate, i0 AM KCN, i mM 
EDTA, pH 7.6, adding 75 PM NADH, 30 PM DB, and 50 ,@ml of 
protein, in a Sigma ZWS 2 dual wavelength spectrophotometer using 
the wavelength couple 340 minus 380 nm and an extinction coefficient 
of 5.5 mM_’ ,crn-‘. 
Sensitivity to rotenone was assayed measuring specific activity after 
10 min preincubation with increasing concentrations of inhibitor. The 
I,,,, i.e. the inhibitor concentration eliciting half-inhibition, was taken 
as an indication of rotenone sensitivity. 
NADH-ferricyanide reductase activity was used to estimate the con- 
tent of active Complex I in the membrane using 2 mM K-ferricyanide, 
considering half of the turnover maximum (8’ 10’ min-‘) since the 
concentration of ferricyanide was approximately equal to the Km [13]. 
K-ferricyanide is an hydrophilic acceptor and reacts with FMN en- 
zyme-bound redox centre of Complex I; NADH-ferricyanide reductase 
activity was assayed essentially as described by Yagi [14] at 30°C in 
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Fig. 1. Percent distribution in different classes of rotenone concentration half- inhibiting Complex I activity (Iso) in platelet membranes from young 
and aged individuals. 
the same buffer used for NADH-DB reductase, with 2 mM K-ferricya- 
nide, 150pM NADH and 14,@ml of mitochondrial protein, in a Sigma 
ZWS 2 dual wavelength spectrophotometer using the wavelength cou- 
ple 420 minus 500 nm and an extinction coefficient of 1 mM-’ ‘cm-‘. 
The turnover number of NADH-Coenzyme Q reductase, expressing 
the maximal efficiency of enzymatic activity, was calculated by the ratio 
NADH-DB activity:enzyme concentration. 
Data are presented as means *standard deviation. The significance 
of differences was evaluated by the unpaired t-test and accepted when 
P < 0.05. 
3. Results 
The mean platelet volume (fL+), determined in 14 and 13 pools 
respectively from young and aged individuals, was slightly but 
significantly lower in the aged population (9.4 f 0.2 vs. 
8.8 2 0.4, P < 0.05). 
Table 1 shows no difference in the specific activities of both 
Table 1 
Biochemical parameters in platelet membranes from young and aged 
female individuals 
Complex I spec. activity 
(nmol min-’ mg-‘) 
Complex I turnover (s’) 
% rotenone sensitivity 
I,, of rotenone 
(pm01 mg-‘) 
Young (n = 19) 
4.6 k 1.6 
9.8 f 4.6 
76.1 t 9.9 
64.8 + 44.8 
Aged (n = 18) 
4.5 * 0.9 
7.4 f 2.1 
71.8 f 10.0 
126.1 + 106.2* 
Data refer to 19 platelet pools from young individuals and 18 pools 
from aged ones. 
*P < 0.03 
n = number of pools (2 individuals each) 
groups and a slight decrease in the turnover of Complex I in 
aged individuals. 
The overall sensitivity to the specific inhibitor, rotenone, 
added in excess, was similar in both groups (71.8% vs. 76.1%). 
It is worth noting, however, that the mean value of the I,, 
for rotenone inhibition was significantly higher in the aged 
group. 
Fig. 1 reporting the percent distribution in different classes 
of I,, values of Complex I activity in platelet membranes from 
young and aged individuals, exhibits a dramatic shift to higher 
I,, classes in the old population: for example, in the aged group 
I,, values were comprised between 50 and 150 in 60% of the 
cases and between 0 and 50 in 22%, while almost 50% of the 
young showed I,, values between 0 and 50. 
4. Discussion 
The finding of decreased rotenone sensitivity in ageing is 
compatible with the ‘mitochondrial’ theory. The postulated 
increase of somatic mutations of mtDNA will affect mostly 
those enzymes for whose subunits more genes are present. The 
hydrophobic subunits of Complex I, encoded by mtDNA, 
which are responsible among other functions for the sensitivity 
to rotenone and other inhibitors [ 151, are essential to the enzy- 
matic function mainly for the mechanism of Coenzyme Q bind- 
ing and energy conservation through H’ translocation [ 161; it 
can therefore be hypothesized that their alteration leads to 
decreased energy conservation more strongly than to decreased 
electron transfer. Mutations affecting energy conservation in 
Complex I may not be lethal for the cells and may be compat- 
ible with their replication if the other complexes still function, 
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whereas a loss of electron transfer in Complex I would lead to 
loss of activity of the whole respiratory chain with NAD-linked 
substrates. 
The finding of a consistent mitochondrial alteration in plate- 
lets is somewhat surprising, as only postmitotic cells have been 
considered prone to accumulate mtDNA mutations [17]; in 
rapidly dividing cells, or in cells deriving from differentiation 
and then removed, it is expected that age-related changes may 
not accumulate to significant extent, because the defective cells 
would be ‘washed out’ by natural selction. It is considered 
however that these cells, which rely upon glycolysis as well as 
respiration, may develop mitochondrial changes still compati- 
ble with the cell’s energetic function, particularly if the changes 
are not too severe. The choice of a kinetic parameter, as ro- 
tenone sensitivity, was dictated by the type of cell selected for 
this study. Platelets are relatively rich in mitochondria, but are 
known to have probably one copy only of mtDNA per mito- 
chondrion [ 181: thus even if age-related mutations preferentially 
lead to a heteroplasmic state in the cell [19], each mitochon- 
drion, where a significant mutation occurs, would become ener- 
getically defective. The variability in rotenone sensitivity ob- 
served in the aged is expected, since not all mutations and/or 
deletions are expected to alter subunits involved in a single 
parameter as rotenone sensitivity. It is, however, noteworthy 
that the changes are observed in a significantly high number of 
individuals. 
Although the type of lesion and its variability are in accord- 
ance with the expectancies of the mitochondrial theory of aging, 
we cannot exclude other possible reasons for the changes ob- 
served. Rotenone is a very hydrophobic molecule that acts 
through the lipid phase of the membrane: for this reason any 
change of lipid composition and fluidity of the inner mitochon- 
drial membrane could affect its binding properties. It is of 
interest to point out that changes in the relative content of lipid 
classes were observed in senescent rats [20] and in platelets from 
old humans as well [21]. 
As this study was performed on a still limited number of 
subjects, it is at present impossible to directly relate the age of 
examined individuals to their sensitivity to rotenone. However, 
this pilot study is encouraging for the development of a bio- 
marker of ageing: the use of rotenone sensitivity can be devel- 
oped as a diagnostic and prognostic test for both normal ageing 
and development of age-associated diseases: the finding [22] 
that mtDNA ‘common’ deletion is higher in aged heart patients 
than in normal subjects of corresponding age encourages the 
search for a noninvasive test to predict the propensity to de- 
velop chronic diseases of ageing. 
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